Literature DB >> 11934527

Atenolol: pharmacokinetic/dynamic aspects of comparative developmental toxicity.

Sonia A Tabacova1, Carole A Kimmel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11934527     DOI： 10.1016/s0890-6238(01)00193-9

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN： 0890-6238            Impact factor:   3.143


× No keyword cloud information.
  4 in total

1.  Atenolol Renal Secretion Is Mediated by Human Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Proteins.

Authors:  Jia Yin; Haichuan Duan; Yoshiyuki Shirasaka; Bhagwat Prasad; Joanne Wang
Journal:  Drug Metab Dispos       Date:  2015-09-15       Impact factor: 3.922

2.  Atenolol exposure and risk for development of adverse metabolic effects: a pilot study.

Authors:  Hrishikesh A Navare; Reginald F Frye; Rhonda M Cooper-Dehoff; Jonathan J Shuster; Karen Hall; Siegfried O F Schmidt; Stephen T Turner; Julie A Johnson
Journal:  Pharmacotherapy       Date:  2010-09       Impact factor: 4.705

3.  Apple juice greatly reduces systemic exposure to atenolol.

Authors:  Hyewon Jeon; In-Jin Jang; SeungHwan Lee; Kyoichi Ohashi; Tsutomu Kotegawa; Ichiro Ieiri; Joo-Youn Cho; Seo Hyun Yoon; Sang-Goo Shin; Kyung-Sang Yu; Kyoung Soo Lim
Journal:  Br J Clin Pharmacol       Date:  2013-01       Impact factor: 4.335

4.  Evaluation of the Effect of Atenolol Induced Depression in Cardiac Output on Its Own Excretion through Urine Analysis.

Authors:  Safeer Khan; Wajahat Mahmood
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.